160 related articles for article (PubMed ID: 25510219)
1. Successful treatment of occult hepatitis B virus infection related membranous nephropathy after entecavir therapy.
Xiong QF; Zhong YD; Hu ZL; Yang YF
Acta Clin Belg; 2015 Jun; 70(3):223-5. PubMed ID: 25510219
[TBL] [Abstract][Full Text] [Related]
2. Complete remission of hepatitis B virus-related membranous nephropathy after entecavir monotherapy.
Yang YF; Xiong QF; Zhao W; Zhong YD
Clin Res Hepatol Gastroenterol; 2012 Oct; 36(5):e89-92. PubMed ID: 22572521
[TBL] [Abstract][Full Text] [Related]
3. Seroconversion of hepatitis B envelope antigen by entecavir in a child with hepatitis B virus-related membranous nephropathy.
Igarashi T; Shimizu A; Igarashi T; Hanaoka K; Yoshizaki K; Shigemori T; Shimizu S; Komeichi H; Itoh Y
J Nippon Med Sch; 2013; 80(5):387-95. PubMed ID: 24189358
[TBL] [Abstract][Full Text] [Related]
4. Successful Use of Entecavir in Hepatitis B-associated Membranous Nephropathy.
Mahajan V; D'Cruz S; Nada R; Sachdev A
J Trop Pediatr; 2018 Jun; 64(3):249-252. PubMed ID: 28977667
[TBL] [Abstract][Full Text] [Related]
5. Complete remission of nephrotic syndrome of hepatitis B virus-associated membranous glomerulopathy after lamivudine monotherapy.
Chuang TW; Hung CH; Huang SC; Lee CM
J Formos Med Assoc; 2007 Oct; 106(10):869-73. PubMed ID: 17964968
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus-related membranous nephropathy treated with entecavir.
Ikee R; Ishioka K; Oka M; Maesato K; Moriya H; Hidaka S; Ohtake T; Kobayashi S
Nephrology (Carlton); 2010 Mar; 15(2):266. PubMed ID: 20470290
[No Abstract] [Full Text] [Related]
7. Efficacy of entecavir in treating hepatitis B virus-associated membranous nephropathy.
Wang L; Xie B; Zheng Q; Xu L; Ye Z
Rev Esp Enferm Dig; 2020 Nov; 112(11):843-849. PubMed ID: 33054304
[TBL] [Abstract][Full Text] [Related]
8. Entecavir monotherapy is effective in suppressing hepatitis B virus after liver transplantation.
Fung J; Cheung C; Chan SC; Yuen MF; Chok KS; Sharr W; Dai WC; Chan AC; Cheung TT; Tsang S; Lam B; Lai CL; Lo CM
Gastroenterology; 2011 Oct; 141(4):1212-9. PubMed ID: 21762659
[TBL] [Abstract][Full Text] [Related]
9. Membranous nephropathy associated with chronic hepatitis B occurring in a short period after acute hepatitis B virus infection.
Nakahara K; Takahashi H; Okuse C; Shigefuku R; Yamada N; Murao M; Matsunaga K; Koike J; Yotsuyanagi H; Suzuki M; Kimura K; Itoh F
Intern Med; 2010; 49(5):383-8. PubMed ID: 20190469
[TBL] [Abstract][Full Text] [Related]
10. Entecavir versus lamivudine for hepatitis B prophylaxis in patients with haematological disease.
Chen FW; Coyle L; Jones BE; Pattullo V
Liver Int; 2013 Sep; 33(8):1203-10. PubMed ID: 23522150
[TBL] [Abstract][Full Text] [Related]
11. Successful Treatment of Hepatitis B Virus-associated Membranous Nephropathy with Entecavir and Immunosuppressive Agents.
Ochi A; Ishimura E; Ichii M; Ohno Y; Nakatani S; Kobayashi I; Shima H; Tsuda A; Shidara K; Mori K; Tamori A; Inaba M
Nephrology (Carlton); 2014 Sep; 19(9):595-6. PubMed ID: 25156438
[No Abstract] [Full Text] [Related]
12. [Treatment of hepatitis B virus-associated membranous glomerulonephritis with interferon alfa in a 7 year old boy].
Steiss JO; Piske-Keyser K; Gröne HJ; Gortner L
Klin Padiatr; 2000; 212(5):283-6. PubMed ID: 11048290
[TBL] [Abstract][Full Text] [Related]
13. HBV-associated cryoglobulinemic vasculitis: remission after antiviral therapy with entecavir.
Viganò M; Martin P; Cappelletti M; Fabrizi F
Kidney Blood Press Res; 2014; 39(1):65-73. PubMed ID: 25011658
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus-associated glomerulonephritis in HBsAg serological-negative patients.
Li D; Gao G; Jiang H; Tang Z; Yu Y; Zang G
Eur J Gastroenterol Hepatol; 2015 Jan; 27(1):65-9. PubMed ID: 25386761
[TBL] [Abstract][Full Text] [Related]
15. Successful withdrawal of antiviral treatment in kidney transplant recipients with chronic hepatitis B viral infection.
Cho JH; Lim JH; Park GY; Kim JS; Kang YJ; Kwon O; Choi JY; Park SH; Kim YL; Kim HK; Huh S; Kim CD
Transpl Infect Dis; 2014 Apr; 16(2):295-303. PubMed ID: 24628837
[TBL] [Abstract][Full Text] [Related]
16. Quantitative hepatitis B surface antigen levels in patients with chronic hepatitis B after 2 years of entecavir treatment.
Fung J; Lai CL; Young J; Wong DK; Yuen J; Seto WK; Yuen MF
Am J Gastroenterol; 2011 Oct; 106(10):1766-73. PubMed ID: 21826112
[TBL] [Abstract][Full Text] [Related]
17. Entecavir 1mg versus combined lamivudine/adefovir dipivoxil in chronic HBV Egyptian patients resistant to LAM monotherapy, non-randomised controlled study.
Maklad S; Doss W; El Din SS; Hassan K; Zeid AA
Arab J Gastroenterol; 2014 Mar; 15(1):1-5. PubMed ID: 24630505
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of sulodexide might be associated with inhibition of complement system in hepatitis B virus-associated membranous nephropathy: An inspiration from a pilot trial.
Yang Y; Ma L; Wang C; Kong D; Wang Y; Mei C
Eur J Intern Med; 2016 Jul; 32():96-104. PubMed ID: 27160380
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis-B virus associated nephropathies: a clinicopathological study in 14 children.
Ozdamar SO; Gucer S; Tinaztepe K
Pediatr Nephrol; 2003 Jan; 18(1):23-8. PubMed ID: 12488986
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of entecavir treatment for lamivudine-resistant hepatitis B over 3 years: histological improvement or entecavir resistance?
Suzuki Y; Suzuki F; Kawamura Y; Yatsuji H; Sezaki H; Hosaka T; Akuta N; Kobayashi M; Saitoh S; Arase Y; Ikeda K; Kobayashi M; Miyakawa Y; Kumada H
J Gastroenterol Hepatol; 2009 Mar; 24(3):429-35. PubMed ID: 19226381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
